Doctors face challenges in diagnosing Borrelia miyamotoi

Life seemed simpler for doctors treating Lyme disease before the discovery of numerous pathogens in ticks. The Centers for Disease Control and Prevention (CDC) now reports that “a single tick can transmit multiple pathogens, including bacteria, viruses, and parasites.” [1] In fact, between 2004 and 2016, the CDC identified 7 new tick-borne microbes capable of infecting humans.

 

Borrelia miyamotoi, the bacteria which causes relapsing fever, is one of the latest threats. The disease was first reported in the United States in 2013 but has become increasingly more common. B. miyamotoi is carried by black-legged ticks, the same ticks that can transmit Lyme disease. One study found that 2% of nymphal ticks collected in 11 states endemic for Lyme disease were infected with B. miyamotoi.

A recent review by Shapiro and Wormser in the Journal of the American Medical Association, points out the concerns associated with this particular tick-borne disease and how its unique presentation can make it challenging to diagnose.[2]

  • “This bacterium can be transmitted within the first 24 hours of tick attachment.”
  • “The probability of transmission increases with every day an infected tick is allowed to remain attached.”
  • While some patients with Lyme disease may exhibit a rash, “patients infected with B. miyamotoi in the United States typically do not have a rash.” But they may present with “a fever in conjunction with headache (96%), myalgia (84%), arthralgia (76%), and malaise/fatigue (82%).”
  • There are no diagnostic tests for B. miyamotoi infection that have been approved by the US Food and Drug Administration.
  • The fever may be relapsing. [Editor’s note: Fevers often do not relapse.]
  • “Laboratory abnormalities include leukopenia (51%) and thrombocytopenia (60%), which are rarely seen in Lyme disease.” [Editor’s note: These are seen in Ehrlichia and Anaplasmosis.]
  • “Severely immunocompromised patients may develop chronic meningitis.”

Fortunately, doxycycline and amoxicillin have been shown to effectively treat B. miyamotoi infection in patients, including those who are immunocompromised. [Editor’s note: Long-term outcome studies are needed.)

 

Related Articles:

The best antibiotics to treat Borrelia miyamotoi?

“Urban” ticks carry B. burgdorferi sl and B. miyamotoi

Don’t count on a relapsing fever to diagnose B. miyamotoi

 

References:

  1. CDC Vital Signs, Weekly / May 4, 2018 / 67(17);496–501.  https://www.cdc.gov/mmwr/volumes/67/wr/mm6717e1.htm
  2. Shapiro ED, Wormser GP. Lyme Disease in 2018: What Is New (and What Is Not). Jama. 2018;320(7):635-636.


6
Be Part Of The Conversation

avatar
4 Comment threads
2 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
4 Comment authors
Tom GrierDr. Daniel CameronLane PoorLaneLiz Beth Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
Tom Grier
Guest

Because Borrelia myamotoi has been seen as a biofilm embedded in amyloid plaques in Alzheimer’s brains, it is premature for Dr. Shapiro and Dr. Wormser to say that this infection is successfully treated with doxycycline and amoxicillin because in sections of the brain are harder to treat and even harder to determine if the infection is eradicated. Dr. Alan MacDonald’s work needs corroborated and patients with Borrelia myamotoi need to be followed up in a long-term multi-center international brain autopsy study, that looks for persistence of any and all Borrelia species in the brain after antibiotic treatment. We know Borrelia… Read more »

Lane Poor
Guest

2014 study showing miyamotoi to burgdorpheri ratio of 1 to 2 in serum samples from New England from as far back as 1992.
https://wwwnc.cdc.gov/eid/article/20/7/pdfs/13-1587.pdf

Lane
Guest

Current, from a single doctor in RI, miyamotoi/burgdorpheri ratio = 1/5

Using Imugen…

Liz Beth
Guest
Liz Beth

B.Miyamotoi is not susceptible to amoxicillin in vitro. https://www.ncbi.nlm.nih.gov/pubmed/28674060